Precision Therapeutics Inc.
Precision Therapeutics Receives $1,370,000 Investment from CEO and Director, Carl Schwartz
1/18/19: As part of the investment, which is detailed in a Form 8-K filed with the United States Securities and Exchange Commission on January 14, 2019, Mr. Schwartz also received additional warrants to purchase Company common stock.
